• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Rallybio Corporation - Common Stock (NQ:RLYB)

    16.64 +0.24 (+1.46%)
    Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 6,186
    Open 16.62
    Bid (Size) 16.40 (500)
    Ask (Size) 17.46 (100)
    Prev. Close 16.40
    Today's Range 16.40 - 16.79
    52wk Range 3.670 - 17.57
    Shares Outstanding 37,747,433
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Halper Sadeh LLC is Investigating Whether QGEN, VCTR, RLYB are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB
    From Kahn Swick & Foti, LLC
    Via Business Wire

    Performance

    52-Week Range 5.3% below 52-week high
    16.64
    3.6752W Low 17.5752W High
    1 Week 0.9% below 1-week high
    16.161W Low 16.791W High

    Rallybio Corporation - Common Stock (RLYB) traded between $3.67 and $17.57 over the past 52 weeks and last traded at $16.64, 5.3% below its 52-week high. Over the past week it ranged between $16.16 and $16.79.

    Past 12 Months
    +1.8%
    -1.3%
    +2.0%
    +92.8%
    +194.1%
    +246.7%
    1W +$0.29
    1M -$0.22
    3M +$0.33
    6M +$8.01
    YTD +$10.98
    1Y +$11.84

    RLYB was +246.7% over the past year, +92.8% over six months, +194.1% year to date, +1.8% in the last week.

    12 Months vs Market
    RLYB
    +246.7%
    DIA
    +11.6%
    SPY
    +13.1%
    QQQ
    +15.4%
    IWM
    +11.9%

    Over the past 12 months RLYB returned +246.7% versus DIA (Dow) +11.6%, SPY (S&P 500) +13.1%, QQQ (Nasdaq 100) +15.4% and IWM (Russell 2000) +11.9%.

    Volume & Liquidity 0.41× 3-mo avg
    Today 6,186 3-mo avg 15.0K
    1W
    27.2K
    1M
    12.8K
    3M
    15.0K
    6M
    128.6K
    YTD
    124.6K
    1Y
    106.2K

    RLYB most recently traded 6,186 shares against a 3-month average daily volume of 15.0K.

    More News

    Read More
    News headline image
    Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    Halper Sadeh LLC is Investigating Whether RLYB, KALV, INM, TMHC are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    RALLYBIO CORP (NASDAQ:RLYB) Passes Minervini Trend and High Growth Momentum Filters ↗
    Via Chartmill
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Taylor Morrison Home Corporation (NYSE - TMHC), Rallybio Corporation (Nasdaq – RLYB), InMed Pharmaceuticals, Inc. (Nasdaq – INM), KalVista Pharmaceuticals, Inc.
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    RLYB Stock Alert: Halper Sadeh LLC is Investigating Whether Rallybio Corporation is Obtaining a Fair Price for its Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement
    From Rallybio Corporation
    Via Business Wire
    These stocks are moving in today's session ↗
    Via Chartmill
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Via Chartmill
    Traders are paying attention to the gapping stocks in Monday's session. ↗
    Via Chartmill
    Discover the top movers in Monday's pre-market session. ↗
    Via Chartmill
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC is Investigating Whether RLYB, TALK, UNF are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rallybio Corporation (Nasdaq – RLYB), SunOpta Inc. (Nasdaq – STKL), Talkspace, Inc. (Nasdaq - TALK), Kennedy-Wilson Holdings, Inc. (Nasdaq - KW)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC is Investigating Whether TALK, JTAI, RLYB are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Monday's session: top gainers and losers ↗
    Via Chartmill
    News headline image
    RLYB Stock Alert: Halper Sadeh LLC is Investigating Whether Rallybio Corporation is Obtaining a Fair Deal for its Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Rallybio Corporation and Candid Therapeutics Announce Merger Agreement
    From Candid Therapeutics, Inc.
    Via Business Wire
    News headline image
    Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement
    From Rallybio Corporation
    Via Business Wire
    News headline image
    Rallybio Announces Reverse Stock Split of Common Stock
    From Rallybio Corporation
    Via Business Wire
    News headline image
    RALLYBIO CORP (NASDAQ:RLYB) Reports Q3 2025 Earnings Beat Fueled by Asset Sale and Advances Clinical Pipeline ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates
    From Rallybio Corporation
    Via Business Wire

    Frequently Asked Questions

    Is Rallybio Corporation - Common Stock publicly traded?
    Yes, Rallybio Corporation - Common Stock is publicly traded.
    What exchange does Rallybio Corporation - Common Stock trade on?
    Rallybio Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Rallybio Corporation - Common Stock?
    The ticker symbol for Rallybio Corporation - Common Stock is RLYB on the Nasdaq Stock Market
    What is the current price of Rallybio Corporation - Common Stock?
    The current price of Rallybio Corporation - Common Stock is 16.64
    When was Rallybio Corporation - Common Stock last traded?
    The last trade of Rallybio Corporation - Common Stock was at 10/23/26 04:00 PM ET
    What is the market capitalization of Rallybio Corporation - Common Stock?
    The market capitalization of Rallybio Corporation - Common Stock is 628.12M
    How many shares of Rallybio Corporation - Common Stock are outstanding?
    Rallybio Corporation - Common Stock has 628M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.